Fallon M. Opioid rotation: does it have a role?Palliat Med1997; 11: 177–178.
2.
Foley KM. Clinical tolerance to opioids. In: Basbaum A, Besson, JM eds Towards a new pharmacotherapy of pain. New York: John Wiley, 1991: 181–203.
3.
Yaksh TL, Harty G. Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine. J Pharmacol Exp Ther1988; 244: 501–507.
4.
Parkinson SK, Bailly SL, Little WL, Mueuller JB. Myoclonic seizure activity with chronic high-dose spinal opioid administration. Anaesthesiology1990; 72: 743–745.
5.
Sjøren P, Jonsson T, Jensen NH, Drench NE, Jensen TS. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain1993; 55: 93–97.
6.
Yaksh TL, Harty GJ, Onofrio BM. High doses of spinal morphine produce a non-opiate receptor-mediated hyperesthesia: clinical and theoretical implications. Anesthesiology1986; 64: 590–597.
7.
Hamon M, Bourgoin S, Le Bars D, Cesselin F. In vivo and in vitro release of central neurotransmitters in relation to pain and analgesia. Prog Brain Res1988; 77: 431–444.
8.
Siegal S. Morphine tolerance acquisition as an associative process. J Exp Psych Anim Beh Proc1997; 3: 1–13.
9.
Cox BM. Molecular and cellular mechanisms in opioid tolerance. In: Towards a new pharmaco-therapy of pain. New York: John Wiley, 1991: 137–156.
10.
Houde RW. Nathan B Eddy Memorial Lecture: The analgesic connection. In: Harris LS ed. Problems of drug dependence 1984Proceedings of the 46th Annual Scientific meeting, The Committee on Problems of Drug Dependence. Inc., NIDA Research Monograph 1985: 55; 4–13.
11.
Vigano A, Fan D, Bruera E. Individualised use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators. Pain1996; 67: 115–119.
12.
Crews JC, Sweeney NJ, Denson DD. Clinical efficacy of methadone in patients refractory to other [.mu]-opioid receptor agonist analgesics for management of terminal cancer pain. Cancer1993; 72: 2266–2272.
13.
Inturisi CE, Portenoy RK, Max MB et al. Pharmacokinetic–pharmacodynamic (PK–PD) relationships of methadone infusions in patients with cancer pain. Clin Pharm Ther1990; 47: 565–577.